Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
thomasw 
04.01.22 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.03
17.02.21
€3.00
17.02.22
-24.32%
25.12.21

Could be very worthwhile Investment >20% year
Leading role in innovation
Future proof or reliable business model
DaxiDriver 
17.02.21 60%
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
skatcup 
11.12.21 100%
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€22.15
12.04.21
€28.35
12.04.22
-51.96%
24.12.21

Could be worthwhile Investment >10% per year
melinda 
12.04.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€12.34
13.09.21
€9.00
13.09.22
100.65%
16.12.21

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
13.09.21 90%
sell
Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Snowman 
28.06.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€11.84
13.09.21
-
13.09.22
139.19%
29.11.21

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Amped 
13.09.21 0%
buy
Valneva SE

Start price
Target price
Perf. (%)
€21.24
15.11.21
€25.00
15.11.22
33.24%
27.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
skatcup 
15.11.21 90%
sell
Boiron S.A.

Start price
Target price
Perf. (%)
€38.55
13.04.21
€36.00
13.04.22
-1.30%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
13.04.21 50%
buy
Valbiotis

Start price
Target price
Perf. (%)
€7.05
26.09.21
€7.50
26.09.22
-11.49%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
26.09.21 50%
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€10.08
09.10.21
€12.00
09.10.22
-20.04%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
09.10.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€24.38
25.11.21
€21.00
25.11.22
6.64%
26.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
25.11.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.24
20.07.21
€20.00
20.07.22
116.90%
25.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
20.07.21 50%
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€5.86
07.10.21
€7.50
07.10.22
-8.28%
24.11.21

Could be worthwhile Investment >10% per year
melinda 
07.10.21 50%
sell
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.24
17.11.21
€1.80
17.11.22
0.00%
19.11.21

Could be worthwhile Investment >10% per year
melinda 
17.11.21 50%
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.19
11.11.21
-
11.11.22
2.28%
17.11.21

Could be worthwhile Investment >10% per year
melinda 
11.11.21 0%
buy
Adocia

Start price
Target price
Perf. (%)
€7.54
16.11.20
€10.00
16.11.21
18.04%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
yester 
16.11.20 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
melinda 
15.11.20 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.59
31.10.21
€30.00
31.10.22
8.63%
13.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
skatcup 
31.10.21 80%
sell
bioMerieux S.A.

Start price
Target price
Perf. (%)
€107.60
07.11.21
€100.00
07.11.22
-1.02%
08.11.21

Could be worthwhile Investment >10% per year
melinda 
07.11.21 50%
buy
bioMerieux S.A.

Start price
Target price
Perf. (%)
€111.90
12.04.21
€120.00
12.04.22
-3.84%
07.11.21

Could be worthwhile Investment >10% per year
melinda 
12.04.21 50%
buy
Virbac S.A.

Start price
Target price
Perf. (%)
€395.50
25.10.21
€480.00
25.10.22
1.52%
07.11.21

Could be worthwhile Investment >10% per year
melinda 
25.10.21 50%
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€3.53
03.11.20
€10.50
04.11.21
51.47%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
03.11.20 50%
sell
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
-
04.11.21
-72.31%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
19.10.20 50%